These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6584941)

  • 1. Prostaglandin D2 inhibits the proliferation of human malignant tumor cells.
    Sakai T; Yamaguchi N; Shiroko Y; Sekiguchi M; Fujii G; Nishino H
    Prostaglandins; 1984 Jan; 27(1):17-26. PubMed ID: 6584941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin D2 inhibits the proliferation of human neuroblastoma cells.
    Sakai T; Yamaguchi N; Kawai K; Nishino H; Iwashima A
    Cancer Lett; 1983 Jan; 17(3):289-94. PubMed ID: 6572553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of PGD2 and 9-deoxy-delta 9-PGD2 on colony formation of murine osteosarcoma cells.
    Tanaka H; Yamamuro T; Matsumoto M; Kotoura Y; Tanaka C
    Prostaglandins; 1985 Jul; 30(1):167-74. PubMed ID: 3863195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin D2 strongly inhibits growth of murine mastocytoma cells.
    Kawamura M; Koshihara Y
    Prostaglandins Leukot Med; 1983 Sep; 12(1):85-93. PubMed ID: 6415668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of dyskinesias following the intrastriatal injection of prostaglandins in the rodent.
    Costall B; Holmes SW; Kelly ME; Naylor RJ
    Br J Pharmacol; 1985 Aug; 85(4):943-9. PubMed ID: 3862460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intracerebroventricular administration of prostaglandin D2 on behaviour, blood pressure and body temperature as compared to prostaglandins E2 and F2 alpha.
    Förstermann U; Heldt R; Hertting G
    Psychopharmacology (Berl); 1983; 80(4):365-70. PubMed ID: 6414007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of prostaglandin D2 (PGD2) as an anticoagulative agent for haemodialysis in comparison with prostaglandin E1 (PGE1).
    Nakagawa S; Matsui N; Akiba T; Shinoda T; Fukudome Y; Ozawa K; Baba M; Nakanishi T; Takeuchi J
    Proc Eur Dial Transplant Assoc; 1981; 18():117-21. PubMed ID: 7036145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibition of growth of human endometrial adenocarcinoma cells in vitro treated with prostaglandin F2 alpha, E2, D2 and J2].
    Suzuki H; Sato K; Yoshizumi N; Nishiya I
    Nihon Naibunpi Gakkai Zasshi; 1986 Aug; 62(8):857-66. PubMed ID: 3465609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin synthesis by the cochlea.
    Kawata R; Urade Y; Tachibana M; Mizukoshi O
    Prostaglandins; 1988 Feb; 35(2):173-84. PubMed ID: 3129756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin D2, a potential antineoplastic agent.
    Fukushima M; Kato T; Ueda R; Ota K; Narumiya S; Hayaishi O
    Biochem Biophys Res Commun; 1982 Apr; 105(3):956-64. PubMed ID: 6953969
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostaglandin D2 reduces intraocular pressure.
    Goh Y; Nakajima M; Azuma I; Hayaishi O
    Br J Ophthalmol; 1988 Jun; 72(6):461-4. PubMed ID: 3164634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the contractile activity of PGD2 and PGF2 alpha on human isolated bronchus.
    Black JL; Armour CL; Vincenc KS; Johnson PR
    Prostaglandins; 1986 Jul; 32(1):25-31. PubMed ID: 3464041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased level of salivary prostaglandins in patients with major depression.
    Ohishi K; Ueno R; Nishino S; Sakai T; Hayaishi O
    Biol Psychiatry; 1988 Feb; 23(4):326-34. PubMed ID: 3422573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of testicular testosterone levels in rats by prostaglandin E2.
    Yamada K; Ohkura N; Satoh T
    Res Commun Chem Pathol Pharmacol; 1985 Jan; 47(1):153-6. PubMed ID: 3856906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human gingival carcinoma cell growth by prostaglandins.
    Suzuki K; Kobayashi N; Moriya Y; Abiko Y; Suzuki H
    Gen Pharmacol; 1988; 19(2):273-6. PubMed ID: 3162424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anhydrolevuglandin D2 inhibits the uterotonic activity of prostaglandins F2 alpha and D2.
    Foreman D; Levison BS; Miller DB; Salomon RG
    Prostaglandins; 1988 Jan; 35(1):115-22. PubMed ID: 3163807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro modulation of proliferation and melanization of S91 melanoma cells by prostaglandins.
    Abdel-Malek ZA; Swope VB; Amornsiripanitch N; Nordlund JJ
    Cancer Res; 1987 Jun; 47(12):3141-6. PubMed ID: 2438034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different responsiveness of a variety of isolated dog arteries to prostaglandin D2.
    Toda N
    Prostaglandins; 1982 Jan; 23(1):99-112. PubMed ID: 6950464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence against the formation of 13,14-dihydro-15-keto-prostaglandin F2 alpha following inhalation of prostaglandin D2 in man.
    Hardy CC; Holgate ST; Robinson C
    Br J Pharmacol; 1986 Mar; 87(3):563-8. PubMed ID: 3467804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinergic-mediated bronchoconstriction induced by prostaglandin D2, its initial metabolite 9 alpha,11 beta-PGF2, and PGF2 alpha in asthma.
    Beasley R; Varley J; Robinson C; Holgate ST
    Am Rev Respir Dis; 1987 Nov; 136(5):1140-4. PubMed ID: 2960256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.